In the last trading session, 1.59 million shares of the Outset Medical Inc (NASDAQ:OM) were traded, and its beta was 2.02. Most recently the company’s share price was $0.71, and it changed around -$0.01 or -0.95% from the last close, which brings the market valuation of the company to $36.91M. OM currently trades at a discount to its 52-week high of $14.60, offering almost -1956.34% off that amount. The share price’s 52-week low was $0.57, which indicates that the current value has risen by an impressive 19.72% since then. We note from Outset Medical Inc’s average daily trading volume that its 10-day average is 3.24 million shares, with the 3-month average coming to 1.79 million.

Outset Medical Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.25. If we narrow it down even further, the data shows that 1 out of 8 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended OM as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Outset Medical Inc is expected to report earnings per share of -0.42 for the current quarter.

Outset Medical Inc (NASDAQ:OM) trade information

Instantly OM has showed a red trend with a performance of -0.95% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.7585 on recent trading dayincreased the stock’s daily price by 6.39%. The company’s shares are currently down -86.90% year-to-date, but still up 6.70% over the last five days. On the other hand, Outset Medical Inc (NASDAQ:OM) is -80.90% down in the 30-day period. We can see from the shorts that 7.1 million shares have been sold at a short interest cover period of 12.44 day(s).

The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 88.17% from its current value. Analyst projections state that OM is forecast to be at a low of $3 and a high of $34.

Outset Medical Inc (OM) estimates and forecasts

Outset Medical Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -80.95 percent over the past six months and at a 31.48% annual growth rate that is well above the industry average of 20.40%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 40.80% in revenue this quarter, and will report an increase of 37.30% in the next quarter. The year-over-year growth rate is expected to be -11.30%, down from the previous year.

Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 29.11M in revenue for the current quarter. 6 analysts expect Outset Medical Inc to make 31.12M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 30.39M and 30.51M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -4.20%. Forecasts for the next quarter put sales growth at 2.00%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -15.08%.

OM Dividends

Outset Medical Inc’s next quarterly earnings report is expected to be released in September.

Outset Medical Inc (NASDAQ:OM)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 2.15% of Outset Medical Inc shares, and 94.83% of them are in the hands of institutional investors. The stock currently has a share float of 96.91%. Outset Medical Inc stock is held by 169.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 15.1214% of the shares, which is about 7.7 million shares worth $29.63 million.

AMERIPRISE FINANCIAL INC, with 10.2162% or 5.2 million shares worth $20.02 million as of 2024-06-30, holds the second largest percentage of outstanding shares.